Study number 8539-034
Dates
Oct 21 2025-Mar 11 2026
Location
Dallas, Texas
Age
18-65
Gender
Both Males and Females
Smoker
No
Compensation
17,928
Group
Pt B 4a OR 4b
The investigational drug in this research study is being developed for the treatment of vitiligo, a disease that causes loss of skin color in patches, and related autoimmune disorders. This is the first time that this study drug is being given to humans.
Fortrea Dallas, Tx is recruiting for:
- Healthy Men and Women, age 18-65
- Body Mass Index between 18-32
- Study involves 3 separate stays totaling 15 nights & 9 follow-up visits
- Compensation up to $17,928 may be provided for time and participation
- Refer a friend to receive $350 per qualified referral
*Females must be of nonchildbearing potential
Pt B C4a:
Check-in: Oct 21, Nov 18, Dec 16
Check-out: Oct 31, Nov 20, Dec 19
Follow-up: Nov 5, 25, Dec 3, 23, 31, Jan 14, 28, Feb 11, Mar 11
OR
Pt B C4b:
Check-in: Oct 22, Nov 19, Dec 17
Check-out: Nov 1, 21, Dec 20
Follow-up: Nov 6, 26, Dec 4, 24, Jan 2, 15, 29, Feb 12, Mar 12